Market Movement Analysis: Butterfly Network Surges on September 17 Due to Merge Collaboration, Performance Growth, and Portable Ultrasound

1. On September 15, at the Morgan Stanley Global Healthcare Conference, the company introduced that it is leveraging its semiconductor imaging platform, intellectual property, long-term agreements, and new products to expand its market size and drive recurring revenue growth.
2. On September 1, the company signed a multi-year licensing agreement with Merge Labs to provide Poseidon series Ultrasound-on-Chip technology. The agreement includes an upfront payment, milestone licensing fees, hardware purchase commitments, technology access fees, and ongoing royalties on future commercial sales.
3. On August 6, the company disclosed second quarter revenue of $32.6 million, a year-on-year increase of 39%, with a gross margin of 71.4%. Embedded business revenue was $10.8 million, up 439% year-on-year. The company also raised its 2026 revenue guidance to $119 million to $123 million.

(Disclaimer: This content is a summary generated by AI technology based on publicly available information, for reference only and does not constitute investment advice.)